Bay City Capital
Bay City Capital LLC (Bay City Capital) was established in 1997 for the purpose of managing investment funds in the life sciences industry. Since that date, they have managed six venture funds representing $1.5 billion in capital invested in over 70...Founded in 1997
Homepage: http://www.baycitycapital.com
San Francisco
USA CA
Phone: 415.676.3830
Bay City Capital at CrunchBase
Judy Koh Chief Financial Officer
Past
March, 2013
Bay City Capital invested $20M in NABsys as a Series D round
Bay City Capital invested $48M in Nevro as a Series C round
February, 2013
Bay City Capital invested $10M in Aviir as a Series F round
April, 2012
Bay City Capital invested $5M in SynGen as a Series A round
February, 2012
Bay City Capital invested $12.5M in Altheos as a Series A round
December, 2011
Bay City Capital invested $10M in Aviir as a Series E round
October, 2011
Bay City Capital invested $42M in Dermira as a Series A round
July, 2011
Bay City Capital invested $58M in Nevro as unattributed round
February, 2011
Bay City Capital invested $20M in Conatus Pharmaceuticals as a Series B round
January, 2011
Bay City Capital invested $45M in NextWave Pharmaceuticals as a Series C round
October, 2010
Bay City Capital invested $46M in IDEV Technologies as a Series D round
April, 2010
Bay City Capital invested $20M in Altheos as a Series A round
January, 2010
Bay City Capital invested $29.3M in Merus as a Series B round
Bay City Capital invested $4.2M in Aviir as debt_round round
November, 2009
Bay City Capital invested $8.6M in Metabolex as unattributed round
Bay City Capital invested $50M in Calypso Medical as a Series E round
October, 2009
Bay City Capital invested $32M in Epizyme as a Series B round
April, 2009
Bay City Capital invested $43.5M in Sunesis Pharmaceuticals as unattributed round
March, 2009
Bay City Capital invested $10M in VIA Pharmaceuticals as debt_round round
March, 2008
Bay City Capital invested $30M in BrainCells as a Series B round
January, 2008
Bay City Capital invested $25M in Aragon Surgical as a Series B round
October, 2007
Bay City Capital invested $11.3M in Aviir as a Series B round
August, 2007
Bay City Capital invested $26M in Presidio Pharmaceuticals as a Series B round
May, 2007
Bay City Capital invested $2M in Vivaldi Biosciences as a Series A round
April, 2007
Bay City Capital invested $32M in Metabolex as a Series D round
March, 2007
Bay City Capital invested $50M in MAP Pharmaceuticals as a Series D round
Bay City Capital invested $55M in Phenomix as a Series C round
November, 2005
Bay City Capital invested $26.6M in PTC Therapeutics as unattributed round
August, 2002
Bay City Capital invested unknown amount in Epocrates as a Series C round
August, 2000
Bay City Capital invested $35M in Epocrates as a Series B round
1997
Bay City Capital was founded in 1997